Lawson CA, Bolaños BG, Vargas PN

Language: Spanish
References: 10
Page: 607-610
PDF size: 196.41 Kb.

ABSTRACT

The antiphospholipid syndrome is a disorder characterized by recurrent venous or arterial thromboembolic events, or pregnancy morbidity. In addition to these clinical manifestations, there are autoantibodies that target specific phospholipid-binding proteins. Although the presence of these autoantibodies is what help us to make the diagnosis, but the actual mechanism whereby these autoantibodies cause hypercoagulable state remains elusive.

REFERENCES

1. Berek, J (2012). Berek y Novak Ginecología. 15º edición. Editorial Wolters Klumer, Lippincott Williams & Wilkins.

2. Correa, A et al. (2002). Síndrome Antifosfolipidos y embarazo. Revista Chilena de obstetricia y ginecología.

3. Cunningham, F et al. (2014). Williams Obstetrics. Edición 24. Editorial McGraw-Hill.

4. D’Ippolito, Silvia et al. (2014). Obstetric antiphospholipid syndrome: A recent classification for an old defined disorder. Autoimmunity Reviews. Ed Elsevier.

5. Jayakody, D et al. (2013). Use of New Oral Anticoagulants in Antiphospholipid Syndrome. Springer Science+Business Media USA.

6. Kenji Oku et al. (2012) Pathophysiology of thrombosis and pregnancy morbidity in the antiphospholipid síndrome. European Journal of Clinical Investigation.

7. Lockshin, Michael (2012). Pregnancy and Antiphospholipid Syndrome. American Journal of Reproductive Immunology.

8. Ribeiro, G et al. (2012). Management of Obstetric Antiphospholipid Syndrome. Springer. USA.

9. Rodríguez, J et al. (2013). Avances de interés clínico en el diagnóstico y tratamiento de los pacientes con síndrome antifosfolípido. Revista Clínica Española.

10. Rhodes, E. (2013). Managing haematological disorders duringpregnancy. Ed. Elsevier. USA